Your browser doesn't support javascript.
loading
[Analysis of clinical characteristics and prognosis of 235 pancreatic neuroendocrine tumors underwent Sunitinib treatment].
Xu, J M; Cui, H T; Jia, R; Zhao, C H; Zhao, P.
Affiliation
  • Xu JM; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
  • Cui HT; Department of Oncology, the 940 Hospital of Joint Service of People's Liberation Army, Lanzhou 730050, China.
  • Jia R; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
  • Zhao CH; Department of Gastroenterological Oncology, the Fifth Medical Centre, Chinese PLA General Hospital, Beijing 100071, China.
  • Zhao P; Cancer Foundation of China, Beijing 100021, China.
Zhonghua Zhong Liu Za Zhi ; 43(3): 324-328, 2021 Mar 23.
Article in Zh | MEDLINE | ID: mdl-33752313
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors Type of study: Observational_studies / Prognostic_studies Limits: Child, preschool / Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2021 Document type: Article Affiliation country: China Country of publication: China
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Neuroendocrine Tumors Type of study: Observational_studies / Prognostic_studies Limits: Child, preschool / Humans Country/Region as subject: Asia Language: Zh Journal: Zhonghua Zhong Liu Za Zhi Year: 2021 Document type: Article Affiliation country: China Country of publication: China